Sonid Inc. Shares May Have Slumped 25 percent But Getting In Cheap Is Still Unlikely - Simply Wall St
| 123330 Stock | KRW 27,150 700.00 2.51% |
About 62% of Genic's investor base is looking to short. The analysis of current outlook of investing in Genic Co suggests that many traders are alarmed regarding Genic's prospects. The current market sentiment, together with Genic's historical and current headlines, can help investors time the market. In addition, many technical investors use Genic stock news signals to limit their universe of possible portfolio assets.
Genic |
Sonid Inc. Shares May Have Slumped 25 percent But Getting In Cheap Is Still Unlikely Simply Wall St
Read at news.google.com
 |
Genic Fundamental Analysis
We analyze Genic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Genic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genic stock to make a market-neutral strategy. Peer analysis of Genic could also be used in its relative valuation, which is a method of valuing Genic by comparing valuation metrics with similar companies.
Peers
Genic Related Equities
| 139130 | Dgb Financial | 1.08 | ||||
| 086790 | Hana Financial | 0.17 | ||||
| 005940 | NH Investment | 0.07 | ||||
| 016610 | DB Financial | 0.19 | ||||
| 005945 | Nh Investment | 0.25 | ||||
| 014570 | Korean Drug | 0.61 |
Complementary Tools for Genic Stock analysis
When running Genic's price analysis, check to measure Genic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genic is operating at the current time. Most of Genic's value examination focuses on studying past and present price action to predict the probability of Genic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genic's price. Additionally, you may evaluate how the addition of Genic to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |